Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F®) versus highly purified urinary FSH (Metrodin HP®): Results of a randomized comparative study in women undergoing assisted reproductive techniques

Human Reproduction

Volumn 12, Issue 10, 1997, Pages 2133-2139

  Bergh, C ^a   Howles, C M ^c   Borg, K ^b   Hamberger, L ^a   Josefsson, B ^c   Nilsson, L ^a   Wikland, M ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Fertility Center Scandinavia   (Sweden)

^c Serono International SA   (Switzerland)

Author keywords

Highly purified u hFSH; ICSI; IVF; Multiple follicular development; r hFSH

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN AGONIST; RECOMBINANT FOLLITROPIN; UROFOLLITROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG PURITY; DRUG SAFETY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OOCYTE; OOCYTE MATURATION; OVARY HYPERSTIMULATION; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030778063     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/12.10.2133     Document Type: Article

References (34)

1. Albano, C., Smitz, J., Camus, M. et al. (1996) Pregnancy and birth in an in-vitro fertilization cycle after controlled ovarian stimulation in a woman with a history of allergic reaction to human menopausal gonadotrophin. Hum. Reprod., 11, 1632-1634.
2. Chappel, S., Kelton, C. and Nugent, N. (1992) Expression of human gonadotropins by recombinant DNA methods. In Genazzani, A.R and Petraaglia, F. (eds), Proceedings of the 3rd World Congress on Gynecological Endocrinology. Parthenon Publishing Group, Carnforth, UK, pp. 179-184.
3. de Leeuw, R., Mulders, J., Voortman, G. et al. (1996) Structure-function relationship of recombinant follicle stimulating hormone (Puregon®). Mol. Hum. Reprod., 2, 361-369.
4. Delvigne, A., Dubois, M., Battheu, B. et al. (1993) The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. II. Multiple discriminant analysis for risk prediction. Hum. Reprod., 8, 1361-1366.
5. Giudice, E., Crisci, C., Eshkol, A. et al. (1994) Composition of commercial gonadotrophin preparations extracted from human post-menopausal urine: characterization of non-gonadotrophin proteins. Hum. Reprod., 9, 2291-2299.
6. Habu-Heija, A.T., Yates, R.W.S., Barrett, T. et al. (1995) A comparison of two starting doses of human menopausal gonadotrophin for follicle stimulation in unselected patients for in-vitro fertilization. Hum. Reprod., 10, 801-803.
7. Harris, S.D., Anobile, C.J., McLoughlin, J.D. et al. (1996) Internal carbohydrate complexity of the oligosaccharide chains of recombinant human follicle stimulating hormone (Puregon®). Mol. Hum. Reprod., 2, 807-811.
8. Hedon, B., Out, H.J., Hugues, J.N. et al. (1995) Efficacy and safety of recombinant follicle stimulating hormone (Puregon) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization: a prospective, randomized, assessor-blind, multicentre trial. Hum. Reprod., 10, 3102-3106.
9. Howles, C.M. (1996) Genetic engineering of human FSH (Gonal-F). Hum. Reprod. Update, 2, 172-191.
10. Howles, C.M., Loumaye, E., Giroud, D. et al. (1994) Multiple follicular development and ovarian steroidogenesis following subcutaneous administration of a highly purified urinary FSH preparation in pituitary desensitized women undergoing IVF: a multicentre European phase III study. Hum. Reprod., 9, 424-430.
11. Human Fertilisation and Embryology Authority (1995) Fourth Annual Report.
12. Imthurn, B., Macas, E., Rosselli, M. et al. (1996) Nuclear maturity and oocyte morphology after stimulation with highly purified follicle stimulating hormone compared to human menopausal gonadotrophin. Hum. Reprod., 11, 2387-2391.
13. Jansen, C.A.M. and Van Os, H.C. (1996) Puregon with analogues: an oxymoron. Gynecol. Endocrinol., 10 (Suppl. 1), 34.
14. Le Cotonnec, J.Y., Porchet, H., Beltrami, V. et al. (1993) Comparative pharmacokinetics of two urinary human follicle stimulating hormone preparations in healthy female and male volunteers. Hum. Reprod., 8, 1604-1611.
15. Loumaye, E., Campbell, R. and Salat-Baroux, J. (1995) Human follicle-stimulating hormone produced by recombinant DNA technology: a review for clinicians. Hum. Reprod. Update, 1, 188-199.
16. Loumaye, E., Martineau, I., Piazzi, A. et al. (1996) Clinical assessment of human gonadotrophins produced by recombinant DNA technology. Hum. Reprod., 11 (Suppl. 1), 95-107.
17. Nijs, M., Geerts, L., Van Roosendaal, E. et al. (1993) Prevention of multiple pregnancies in an in vitro fertilization program. Fertil. Steril., 59, 1245-1250.
18. Olijve, W., De Boer, W., Mulders, J.W.M. et al. (1996) Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon). Mol. Hum. Reprod., 2, 371-382.
19. Out, H.J., Mannaerts, B.M.J.L., Driessen, S.G.A.J. et al. (1995) A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum. Reprod., 10, 2534-2540.
20. Out, H.J., Mannaerts, B.M.J.L. and Driessen, S.G.A.J. (1996) Recombinant follicle stimulating hormone (r-hFSH) in assisted reproduction: more oocytes, more pregnancies. Results from five comparative studies. Hum. Reprod. Update, 2, 162-171.
21. Pellicer, A., Valbuena, D., Cano, F. et al. (1996) Lower implantation rates in high responders: evidence for an altered endocrine milieu during the perimplantation period. Fertil. Steril., 65, 1190-1195.
22. Recombinant Human FSH Study Group (1995) Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilisation. Fertil. Steril., 63, 77-86.
23. Redfearn, A., Hughes, E.G., O'Connor, M. et al. (1995) Delayed-type hypersensitivity to human gonadotropin: case report. Fertil. Steril., 64, 855-856.
24. Schenker, J.G. and Weinstein, D. (1978) Ovarian hyperstimulation syndrome: a current survey. Fertil. Steril., 30, 255-268.
25. Simon, C., Cano, F., Valbueno, D. et al. (1995) Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Hum. Reprod., 10, 2427-2432.
26. Staessen, C., Janssenswillen, C., Van Den Abbeel, E. et al. (1993) Avoidance of triplet pregnancies by elective transfer of two good quality embryos. Hum. Reprod., 8, 1650-1653.
27. Steel man, S.L. and Pohley, F.M. (1953) Assay of the follicle stimulating hormone based on the augmentation with human chorionic gonadotropin. Endocrinology, 53, 604-616.
28. Steer, C.V., Mills, C.L., Tan, S.L. et al. (1992) The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme. Hum. Reprod., 7, 117-119.
29. Thornton, S.J. (1996) Starting doses in IVF and effects on outcome. Hum. Reprod., 11, Abstr. Book, 104.
30. Ulloa-Aguirre, A., Midgley, A.R., Jr, Beitinst, I.Z. et al. (1995a) Follicle-stimulating isohormones: characterization and physiological relevance. Endocr. Rev., 16, 765-787.
31. Ulloa-Aguirre, A., Zambrano, E., Timossi, C. et al. (1995b) On the nature of the follicle-stimulating signal delivered to the ovary during exogenously controlled follicular maturation. Arch. Med. Res., 26, 219-230.
32. Van Steirteghem, A.C., Nagy, P., Joris, H. et al. (1996) The development of ICSI. Hum. Reprod., 11 (Suppl. 1), 59-73.
33. Waterstone, J., Parsons, J. and Bolton, V. (1991) Elective transfer of two embryos. Lancet, 337, 975-976.
34. Wikland, M., Borg, J., Hamberger, L. et al. (1994) Simplification of IVF: minimal monitoring and the use of subcutaneous highly purified FSH administration for ovulation induction. Hum. Reprod., 9, 1430-1436.